Tuberculosis Testing Market

Tuberculosis Testing Market (Test Type - Chest X-Ray, Culture Based Tests, IGRA, Mantoux Test (TST), Nucleic Acid Testing (NAT), Xpert Test, Serological Tests, and Smear Microscopy; End-User - Academics and Research, Hospitals Laboratories, Physician's Office Laboratories, and Reference Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017-2025

  • Rep Id : TMRGL2267
  • Published On : Oct 2017
  • No. of Pages : 197
  • Category : Healthcare

Section 1 Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

Section 2 Assumptions and Research Methodology

Section 3 Executive Summary

Section 4 Market Overview
4.1. Introduction
       4.1.1. Product Type Definition
4.2. Overview
4.3. Market Dynamics
       4.3.1. Drivers
                4.3.1.1. Increase in case detection rate in worldwide
                4.3.1.2. Rise in prevalence of drug resistant tuberculosis infection
                4.3.1.3. Improvement in bacteriological confirmation
                4.3.1.4. Rise in awareness enabling proper disease management
                4.3.1.5. Rising demand for improved and technologically advanced tuberculosis testing procedures
                4.3.1.6. Tuberculosis awareness and control programs
       4.3.2. Restraints
                4.3.2.1. Challenges of Mantoux test
                4.3.2.2. High cost of various tuberculosis tests
       4.3.3 Opportunities
                4.3.3.1. Impact of novel tests on the overall market
                4.3.3.2. High potential market for affordable and more effective TB tests
       4.3.4. Trends
4.5. Global Tuberculosis Testing Market Analysis and Forecasts, 2015–2025
4.6. Market Outlook
4.7. Porter's Five Forces Analysis
4.8. Burden of TB Worldwide
4.9. Burden of MDR-TB Worldwide
4.10. Challenges of Traditional Testing/Diagnostic Methods
4.11. Heat Map Analysis –Company
4.12. IGRA (Interferon Gamma Release Assay)
4.13. Smear Microscopy Tests
4.14. Nucleic Acid Testing (NAT)
4.15. Mantoux Test (Tuberculin Test)
4.16. Chest X-Ray
4.17. DST (Drug Susceptibility Testing)
4.18. Culture based method
4.19. Other Tests
4.20. Global R&D spending on Tuberculosis
4.21. Global Changes in TB R&D Funding, 2005–2015
4.22. Global R&D funding on Tuberculosis By Funders
4.23. Tuberculosis Diagnostic Tests Pipeline
4.24. An overview of progress in the development of molecular TB diagnostics
4.25. The phases of TB diagnostics development and assessment for WHO recommendation using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) process

Section 5 Global Tuberculosis Testing Market Analysis, by Test Type
5.1. Key Findings / Developments
5.2. Introduction & Definition
5.3. Global Tuberculosis Testing Market Value Share Analysis, by Test Type
5.4. Global Tuberculosis Testing Market Forecast, by Test Type
       5.4.1. Chest X-Ray
       5.4.2. Culture Based Tests
       5.4.3. IGRA
       5.4.4. Mantoux Test (TST)
       5.4.5. Nucleic Acid Testing (NAT), Xpert test
       5.4.6. Serological Tests
       5.4.7. Smear Microscopy
       5.4.8. Other Tests (ADA, etc.)
5.5. Global Tuberculosis Testing Market Attractiveness, by Test Type

Section 6 Global Tuberculosis Testing Market Analysis, by End-User
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Tuberculosis Testing Market Value Share Analysis, by End-User
       6.4.1. Global Tuberculosis Testing Market Forecast, by End-user
              6.4.2.1. Hospitals Laboratories
              6.4.3.2. Reference Laboratories
              6.4.4.3. Physician’s Office Laboratories
              6.4.5.4. Academics and Research Institutes
              6.4.6.5. Others (home health agencies, etc.)
       6.4.7. Global Tuberculosis Testing Market Attractiveness, by End-User

Section 7 Global Tuberculosis Testing Market Analysis, by Region
7.1. Global Tuberculosis Testing Market Revenue Forecast, 2015-2025
7.2. Introduction
7.3. Global Tuberculosis Testing Market Value Share Analysis, by Region
7.4. Global Tuberculosis Testing Market Forecast, by Region
7.5. Global Tuberculosis Testing Market Attractiveness, by Region

Section 8 North America Tuberculosis Testing Market Analysis
8.1. Introduction
8.2. Key Findings
8.3. North America Tuberculosis Testing Market Overview
8.4. North America Tuberculosis Testing Market Value Share Analysis, by Country
       8.4.1. U.S.
       8.4.2. Canada
8.5. North America Tuberculosis Testing Market Forecast, by Country
       8.6.1. North America Tuberculosis Testing Market Value Share Analysis, by Test Type
       8.6.2. Chest X-Ray
       8.6.3. Culture Based Tests
       8.6.4. IGRA (Interferon-Gamma Release Assays)
       8.6.5. Mantoux Test (TST)
       8.6.6. Nucleic Acid Testing (NAT), Xpert test
       8.6.6. Serological Tests
       8.6.8. Smear Microscopy
       8.6.9. Other Tests (ADA, etc.)
8.7. North America Tuberculosis Testing Market Forecast, by Test Type
8.8. North America Tuberculosis Testing Market Value Share Analysis, by End-User
       8.8.1. Academics and Research
       8.8.2. Hospitals Laboratories
       8.8.3. Physician's Office Laboratories
       8.8.4. Reference Laboratories
       8.8.5. Others (Home Health Agencies, etc.)
8.9. North America Tuberculosis Testing Market Forecast, by End-User
8.10. North America Tuberculosis Testing Market Attractiveness Analysis

Section 9 Europe Tuberculosis Testing Market Analysis
9.1. Introduction
9.2. Key Findings
9.3. Europe Tuberculosis Testing Market Overview
9.4. Europe Tuberculosis Testing Market Value Share Analysis, by Country
     9.4.1. Germany
     9.4.2. U.K.
     9.4.3. France
     9.4.4. Italy
     9.4.5. Spain
     9.4.6. Rest of Europe
9.5. Europe Tuberculosis Testing Market Forecast, by Country
9.6. Europe Tuberculosis Testing Market Value Share Analysis, by Test Type
     9.6.1. Chest X-Ray
     9.6.2. Culture Based Tests
     9.6.3. IGRA (Interferon-Gamma Release Assays)
     9.6.4. Mantoux Test (TST)
     9.6.5. Nucleic Acid Testing (NAT), Xpert test
     9.6.6. Serological Tests
     9.6.7. Smear Microscopy
     9.6.8. Other Tests (ADA, etc.)
9.7. Europe Tuberculosis Testing Market Forecast, by Test Type
9.8. Europe Tuberculosis Testing Market Value Share Analysis, by End-User
     9.8.1. Academics and Research
     9.8.2. Hospitals Laboratories
     9.8.3. Physician's Office Laboratories
     9.8.4. Reference Laboratories
     9.8.5. Others (Home Health Agencies, etc.)
9.9. Europe Tuberculosis Testing Market Forecast, by End-User
9.10. Europe Tuberculosis Testing Market Attractiveness Analysis

Section 10 Asia Pacific Tuberculosis Testing Market Analysis
10.1. Introduction
10.2. Key Findings
10.3. Asia Pacific Tuberculosis Testing Market Overview
10.4. Asia Pacific Tuberculosis Testing Market Value Share Analysis, by Country
        10.4.1. China
        10.4.2. India
        10.4.3. Japan
        10.4.4. Australia & New Zealand
        10.4.5. Rest of Asia Pacific
10.5. Asia Pacific Tuberculosis Testing Market Forecast, by Country
10.6. Asia Pacific Tuberculosis Testing Market Value Share Analysis, by Test Type
        10.6.1. Chest X-Ray
        10.6.2. Culture Based Tests
        10.6.3. IGRA (Interferon-Gamma Release Assays)
        10.6.4. Mantoux Test (TST)
        10.6.5. Nucleic Acid Testing (NAT), Xpert test
        10.6.6. Serological Tests
        10.6.7. Smear Microscopy
        10.6.8. Other Tests (ADA, etc.)
10.7. Asia Pacific Tuberculosis Testing Market Forecast, by Test Type
10.8. Asia Pacific Tuberculosis Testing Market Value Share Analysis, by End-User
        10.8.1. Academics and Research
        10.8.2. Hospitals Laboratories
        10.8.3. Physician's Office Laboratories
        10.8.4. Reference Laboratories
        10.8.5. Others (Home Health Agencies, etc.)
10.9. Asia Pacific Tuberculosis Testing Market Forecast, by End-User
10.10. Asia Pacific Tuberculosis Testing Market Attractiveness Analysis

Section 11 Latin America Tuberculosis Testing Market Analysis
11.1. Introduction
11.2. Key Findings
11.3. Latin America Tuberculosis Testing Market Overview
11.4. Latin America Tuberculosis Testing Market Value Share Analysis, by Country
        11.4.1. Brazil
        11.4.2. Mexico
        11.4.3. Rest of LATAM
11.5. Latin America Tuberculosis Testing Market Forecast, by Country
11.6. Latin America Tuberculosis Testing Market Value Share Analysis, by Test Type
        11.6.1. Chest X-Ray
        11.6.2. Culture Based Tests
        11.6.3. IGRA (Interferon-Gamma Release Assays)
        11.6.4. Mantoux Test (TST)
        11.6.5. Nucleic Acid Testing (NAT), Xpert test
        11.6.6. Serological Tests
        11.6.7. Smear Microscopy
        11.6.8. Other Tests (ADA, etc.)
11.7. Latin America Tuberculosis Testing Market Forecast, by Test Type
11.8. Latin America Tuberculosis Testing Market Value Share Analysis, by End-User
        11.8.1. Academics and Research
        11.8.2. Hospitals Laboratories
        11.8.3. Physician's Office Laboratories
        11.8.4. Reference Laboratories
        11.8.5. Others (Home Health Agencies, etc.)
11.9. Latin America Tuberculosis Testing Market Forecast, by End-User
11.10. Latin America Tuberculosis Testing Market Attractiveness Analysis

Section 12 Middle East and Africa Tuberculosis Testing Market Analysis
12.1. Introduction
12.2. Key Findings
12.3. Middle East and Africa Tuberculosis Testing Market Overview
12.4. Middle East and Africa Tuberculosis Testing Market Value Share Analysis, by Country
          12.4.1. GCC Countries
          12.4.2. South Africa
          12.4.3. Rest of MEA
12.5. Middle East and Africa Tuberculosis Testing Market Forecast, by Country
12.6. Middle East and Africa Tuberculosis Testing Market Value Share Analysis, by Test Type
          12.6.1. Chest X-Ray
          12.6.2. Culture Based Tests
          12.6.3. IGRA (Interferon-Gamma Release Assays)
          12.6.4. Mantoux Test (TST)
          12.6.5. Nucleic Acid Testing (NAT), Xpert test
          12.6.6. Serological Tests
          12.6.7. Smear Microscopy
          12.6.8. Other Tests (ADA, etc.)
12.7. Middle East and Africa Tuberculosis Testing Market Forecast, by Test Type
12.8. Middle East and Africa Tuberculosis Testing Market Value Share Analysis, by End-User
        12.8.1. Academics and Research
        12.8.2. Hospitals Laboratories
        12.8.3. Physician's Office Laboratories
        12.8.4. Reference Laboratories
        12.8.5. Others (Home Health Agencies, etc.)
12.9. Middle East and Africa Tuberculosis Testing Market Forecast, by End-User
12.10. Middle East and Africa Tuberculosis Testing Market Attractiveness Analysis

Section 13 Region/Country Snippets

Section 14 Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of companies)
14.2. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
        14.2.1. Thermo Fisher Scientific, Inc.
        14.2.2. Alere, Inc.
        14.2.3. Becton, Dickinson and Company
        14.2.4. F. Hoffmann-La Roche AG
        14.2.5. LIONEX Diagnostics & Therapeutics GmbH.
        14.2.6. Danaher Corporation
        14.2.7. Creative Diagnostics
        14.2.8. QIAGEN
        14.2.9. Hain Lifescience GmbH
        14.2.10. Oxford Immunotec Ltd.
        14.2.11. Hologic, Inc.
        14.2.12. Cepheid
        14.2.13. Akonni Biosystems, Inc.
        14.2.14. bioMérieux SA
        14.2.15. Epistem Ltd.

List of Tables
 
Table 01: Top 10 High TB burden countries with estimated number of new TB cases globally 
Table 02: Estimated number of MDR-TB among all notified TB cases in high burden countries (2015)
Table 03: TB R&D Funders by Rank in 2015
Table 04: Tuberculosis Diagnostics tests Pipeline
Table 05: Global Tuberculosis Testing Market Size (US$ Mn) Forecast, by Test Type, 2015–2025
Table 06: Global Tuberculosis Testing Market Value (US$ Mn) Forecast, by End-user, 2015–2025
Table 07: Global Tuberculosis Testing Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 08: North America Tuberculosis Testing Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 09: North America Tuberculosis Testing Market Size (US$ Bn) Forecast, by Test Type, 2015–2025
Table 10: North America Tuberculosis Testing Market Size (US$ Bn) Forecast, by End-User, 2015–2025
Table 11: Europe Tuberculosis Testing Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 12: Europe Tuberculosis Testing Market Size (US$ Mn) Forecast, by Test Type, 2015–2025
Table 13: Europe Tuberculosis Testing Market Size (US$ Bn) Forecast, by End-User, 2015–2025
Table 14: Asia Pacific Tuberculosis Testing Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 15: Asia Pacific Tuberculosis Testing Market Size (US$ Mn) Forecast, by Test Type, 2015–2025
Table 16: Asia Pacific Tuberculosis Testing Market Size (US$ Mn) Forecast, by End-User, 2015–2025
Table 17: Latin America Tuberculosis Testing Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 18: Latin America Tuberculosis Testing Market Size (US$ Mn) Forecast, by Test Type, 2015–2025
Table 19: Latin America Tuberculosis Testing Market Size (US$ Mn) Forecast, by End-User, 2015–2025
Table 20: Middle East and Africa Tuberculosis Testing Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 21: Middle East and Africa Tuberculosis Testing Market Size (US$ Mn) Forecast, by Test Type, 2015–2025
Table 22: Middle East and Africa Tuberculosis Testing Market Size (US$ Mn) Forecast, by End-User, 2015–2025

List of Figures  
 
Figure 01: Global Tuberculosis Testing Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
Figure 02: Market Value Share, by Test Type (2016)
Figure 03: Market Value Share, by End User (2016)
Figure 04: Market Value Share, by Region (2016)
Figure 05: Annual Global Plan Research Funding Targets versus 2015 Funding on Tuberculosis
Figure 06: Total TB R&D Funding, 2005–2015
Figure 07: Total TB R&D Funding by Funder Category, 2015
Figure 08: Total TB R&D Funding by Funder Category, 2005–2015 (Mn) 
Figure 09: Global Tuberculosis Testing Market Value Share Analysis, by Test Type, 2016 and 2025
Figure 10: Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Chest X-Ray, 2015–2025
Figure 11: Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Culture Based Tests,
Figure 12: Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by IGRA, 2015–2025
Figure 13: Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Mantoux Test (TST), 2015–2025
Figure 14: Global Tuberculosis Testing Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Nucleic Acid Testing (NAT), Xpert test, 2015–2025
Figure 15: Global Tuberculosis Testing Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Serological Tests,
Figure 16: Global Tuberculosis Testing Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Smear Microscopy, 2015–2025
Figure 17: Global Tuberculosis Testing Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Other Tests (ADA, etc.), 2015–2025
Figure 18: Global Tuberculosis Testing Market Attractiveness, by Test Type, 2017-2025
Figure 19: Global Tuberculosis Testing Market Value Share Analysis, by End-User, 2016 and 2025
Figure 20: Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2015–2025
Figure 21: Global Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Reference Laboratories, 2015–2025
Figure 22: Europe Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Physician’s Office Laboratories, 2015–2025
Figure 23: Europe Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Academics and Research, 2015–2025
Figure 24: Europe Tuberculosis Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2025
Figure 25: Global Tuberculosis Testing Market Attractiveness, by End-User, 2017-2025
Figure 26: Global Tuberculosis Testing Market Revenue (US$ Bn) Forecast, 2015–2025
Figure 27: Global Tuberculosis Testing Market Value Share Analysis, by Region, 2016 and 2025
Figure 28: Global Tuberculosis Testing Market Attractiveness, by Region, 2017-2025
Figure 29: North America Tuberculosis Testing Market Size (US$ Bn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 30: North America Tuberculosis Testing Market Attractiveness Analysis, by Country, 2017–2025
Figure 31: North America Tuberculosis Testing Market Value Share Analysis, by Country, 2016 and 2025
Figure 32: North America Tuberculosis Testing Market Value Share Analysis, by Test Type, 2016 and 2025
Figure 33: North America Tuberculosis Testing Market Value Share Analysis, by End-User, 2016 and 2025
Figure 34: North America Tuberculosis Testing Market Attractiveness Analysis, by Test Type, 2017–2025
Figure 35: North America Tuberculosis Testing Market Attractiveness Analysis, by End-User, 2017–2025
Figure 36: Europe Tuberculosis Testing Market Size (US$ Bn) Forecast, 2015–2025
Figure 37: Europe Market Attractiveness Analysis, by Country, 2017–2025
Figure 38: Europe Tuberculosis Testing Market Value Share Analysis, by Country, 2016 and 2025
Figure 39: Europe Tuberculosis Testing Market Value Share Analysis, by Test Type, 2016 and 2025
Figure 40: Europe Tuberculosis Testing Market Value Share Analysis, by End-User, 2016 and 2025
Figure 41: Europe Tuberculosis Testing Market Attractiveness Analysis, by Test Type, 2017–2025
Figure 42: Europe Tuberculosis Testing Market Attractiveness Analysis, by End-User, 2017–2025
Figure 43: Asia Pacific Tuberculosis Testing Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 44: Asia Pacific Tuberculosis Testing Market Attractiveness Analysis, by Country, 2017–2025
Figure 45: Asia Pacific Tuberculosis Testing Market Value Share Analysis, by Country, 2016 and 2025
Figure 46: Asia Pacific Tuberculosis Testing Market Value Share Analysis, by Test Type, 2016 and 2025
Figure 47: Asia Pacific Tuberculosis Testing Market Value Share Analysis, by End-User, 2016 and 2025
Figure 48: Asia Pacific Tuberculosis Testing Market Attractiveness Analysis, by Test Type, 2017–2025
Figure 49: Asia Pacific Tuberculosis Testing Market Attractiveness Analysis, by End-User, 2017–2025
Figure 50: Latin America Tuberculosis Testing Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 51: Latin America Tuberculosis Testing Market Attractiveness Analysis, by Country, 2017–2025
Figure 52: Latin America Tuberculosis Testing Market Value Share Analysis, by Country, 2016 and 2025
Figure 53: Latin America Tuberculosis Testing Market Value Share Analysis, by Test Type, 2016 and 2025
Figure 54: Latin America Tuberculosis Testing Market Value Share Analysis, by End-User, 2016 and 2025
Figure 55: Latin America Tuberculosis Testing Market Attractiveness Analysis, by Test Type, 2017–2025
Figure 56: Latin America Tuberculosis Testing Market Attractiveness Analysis, by End-User, 2017–2025
Figure 57: Middle East and Africa Tuberculosis Testing Market Size (US$ Mn)  and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 58: Middle East and Africa Tuberculosis Testing Market Attractiveness Analysis, by Country, 2017–2025
Figure 59: Middle East and Africa Tuberculosis Testing Market Value Share Analysis, by Country, 2016 and 2025
Figure 60: Middle East and Africa Tuberculosis Testing Market Value Share Analysis, by Test Type, 2016 and 2025
Figure 61: Middle East and Africa Tuberculosis Testing Market Value Share Analysis, by End-User, 2016 and 2025
Figure 62: Middle East and Africa Tuberculosis Testing Market Attractiveness Analysis, by Test Type, 2017–2025
Figure 63: Middle East and Africa Tuberculosis Testing Market Attractiveness Analysis, by End-User, 2017–2025
Figure 64: Thermo Fisher Scientific, Inc. - Breakdown of Net Sales (% Share), by Business segments (2016)
Figure 65: Thermo Fisher Scientific, Inc. - Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
Figure 66: Alere, Inc. - Revenue Split, by Operating Segment, 2015
Figure 67: Alere, Inc. - Total Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2016
Figure 68: Becton, Dickinson and Company - Breakdown of Net Sales, by Region, 2016
Figure 69: Becton, Dickinson and Company- Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
Figure 70: F. Hoffmann-La Roche AG Breakdown of Net Sales (Pharmaceutical Division), by Region, 2015
Figure 71: F. Hoffmann-La Roche AG- Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2016
Figure 72: Danaher Corporation - Breakdown of Revenue, by Region, 2016
Figure 73: Danaher Corporation - Revenue (US$ Bn) & Y-o-Y Growth (%), 2012–2016
Figure 74: QIAGEN- Breakdown of Net Sales, by Business Segment, 2016
Figure 75: QIAGEN- Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2016
Figure 76: Oxford Immunotec Ltd. - Breakdown of Net Sales, by region, 2015
Figure 77: Oxford Immunotec Ltd. - Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 78:  Hologic, Inc. - Breakdown of Net Sales, by Country/Region, 2015
Figure 79: Hologic, Inc. - Revenue (US$ Mn) and Y-o-Y Growth (%), 2012–2015
Figure 80: Cepheid - Breakdown of Net Sales, by Country/Region, 2015
Figure 81: Cepheid - Revenue (US$ Mn) and Y-o-Y Growth (%), 2012–2015
Figure 82: bioMérieux SA - Breakdown of Net Sales, by Country/Region, 2016
Figure 83: bioMérieux SA - Revenue (US$ Mn) and Y-o-Y Growth (%), 2012–2015
Figure 84: Epistem Ltd. - Breakdown of Net Sales, by Country/Region, 2015
Figure 85: Epistem Ltd. - Revenue (US$ Mn) and Y-o-Y Growth (%), 2012–2015